肖文铉;江一舟;邵志敏

• 1:复旦大学附属肿瘤医院乳腺外科，上海 200032

摘要(Abstract)：

人工智能（artificial intelligence，AI）正在迅速推动乳腺癌诊疗进入精准诊疗时代。由于深度学习算法的出现、计算硬件及算法的进步以及大规模数据集的可用性，使AI在乳腺癌诊疗各方面的应用呈指数级增长。本文对当前AI在乳腺癌精准诊疗中的发展历程以及在包括筛查与预测、病理诊断、治疗和药物研发等方面的主要应用作一综述，并简要展望该领域未来发展方向。

关键词(KeyWords)： 乳腺癌;人工智能;精准诊疗

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 肖文铉;江一舟;邵志敏

DOI: 10.13267/j.cnki.syzlzz.2022.019

参考文献(References)：

• [1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
  [2] Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China[J]. Lancet Oncol, 2014, 15(7):e279-e289.
  [3] Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China:good or bad news from the 2018 Global Cancer Statistics?[J]. Cancer Commun (Lond), 2019, 39(1):22.
  [4] Esteva A, Robicquet A, Ramsundar B, et al. A guide to deep learning in healthcare[J]. Nat Med, 2019, 25(1):24-29.
  [5] Kann BH, Johnson SB, Aerts HJWL, et al. Changes in length and complexity of clinical practice guidelines in oncology, 1996-2019[J]. JAMA Netw Open, 2020, 3(3):e200841.
  [6] LeCun Y, Bengio Y, Hinton G. Deep learning[J]. Nature, 2015, 521(7553):436-444.
  [7] 严律南.人工智能在医学领域应用的现状与展望[J].中国普外基础与临床杂志, 2018, 25(5):513-514.
  [8] 于观贞.人工智能与医学:序言[J].第二军医大学学报, 2018, 39(8):807.
  [9] Bhinder B, Gilvary C, Madhukar NS, et al. Artificial intelligence in cancer research and precision medicine[J]. Cancer Discov, 2021, 11(4):900-915.
  [10] Maddox TM, Rumsfeld JS, Payne PRO. Questions for artificial intelligence in health care[J]. JAMA, 2019, 321(1):31.
  [11] Nagendran M, Chen Y, Lovejoy CA, et al. Artificial intelligence versus clinicians:systematic review of design, reporting standards, and claims of deep learning studies[J]. BMJ, 2020, 368:m689.
  [12] Kuznar W. The push toward value-based payment for oncology[J]. Am Health Drug Benefits, 2015, 8(Spec Issue):34.
  [13] Vyborny CJ, Giger ML. Computer vision and artificial intelligence in mammography[J]. AJR Am J Roentgenol, 1994, 162(3):699-708.
  [14] Kooi T, Litjens G, van Ginneken B, et al. Large scale deep learning for computer aided detection of mammographic lesions[J]. Med Image Anal, 2017, 35:303-312.
  [15] Chereda H, Bleckmann A, Menck K, et al. Explaining decisions of graph convolutional neural networks:patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer[J]. Genome Med, 2021, 13(1):42.
  [16] Pinckaers H, van Ginneken B, Litjens G. Streaming convolutional neural networks for end-to-end learning with multi-megapixel images[J]. IEEE Trans Pattern Anal Mach Intell, 2022, 44(3):1581-1590.
  [17] Shen YQ, Shamout FE, Oliver JR, et al. Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams[J]. Nat Commun, 2021, 12:5645.
  [18] Kim HE, Kim HH, Han BK, et al. Changes in cancer detection and false-positive recall in mammography using artificial intelligence:a retrospective, multireader study[J]. Lancet Digit Health, 2020, 2(3):e138-e148.
  [19] Rodríguez-Ruiz A, Krupinski E, Mordang JJ, et al. Detection of breast cancer with mammography:effect of an artificial intelligence support system[J]. Radiology, 2019, 290(2):305-314.
  [20] St John ER, Al-Khudairi R, Ashrafian H, et al. Diagnostic accuracy of intraoperative techniques for margin assessment in breast cancer surgery:a meta-analysis[J]. Ann Surg, 2017, 265(2):300-310.
  [21] 丰锦春,李宇翔,李丹,等.乳腺癌组织GFRα1、RET及NCAM表达水平与淋巴结转移关系的研究[J].实用肿瘤杂志, 2021, 36(3):247-251.
  [22] Min J, Im H, Allen M, et al. Computational optics enables breast cancer profiling in point-of-care settings[J]. ACS Nano, 2018, 12(9):9081-9090.
  [23] Wang Y, Acs B, Robertson S, et al. Improved breast cancer histological grading using deep learning[J]. Ann Oncol, 2022, 33(1):89-98.
  [24] Rodriques SG, Stickels RR, Goeva A, et al. Slide-seq:a scalable technology for measuring genome-wide expression at high spatial resolution[J]. Science, 2019, 363(6434):1463-1467.
  [25] Zhao TT, Chiang ZD, Morriss JW, et al. Spatial genomics enables multi-modal study of clonal heterogeneity in tissues[J]. Nature, 2022, 601(7891):85-91.
  [26] Peck RW. The right dose for every patient:a key step for precision medicine[J]. Nat Rev Drug Discov, 2016, 15(3):145-146.
  [27] Forbes SA, Beare D, Boutselakis H, et al. COSMIC:somatic cancer genetics at high-resolution[J]. Nucleic Acids Res, 2017, 45(D1):D777-D783.
  [28] Somashekhar SP, Sepúlveda MJ, Puglielli S, et al. Watson for Oncology and breast cancer treatment recommendations:agreement with an expert multidisciplinary tumor board[J]. Ann Oncol, 2018, 29(2):418-423.
  [29] Jiang YZ, Ma D, Suo C, et al. Genomic and transcriptomic landscape of triple-negative breast cancers:subtypes and treatment strategies[J]. Cancer Cell, 2019, 35(3):428-440.
  [30] Paul D, Sanap G, Shenoy S, et al. Artificial intelligence in drug discovery and development[J]. Drug Discov Today, 2021, 26(1):80-93.
  [31] Mak KK, Pichika MR. Artificial intelligence in drug development:present status and future prospects[J]. Drug Discov Today, 2019, 24(3):773-780.
  [32] Sellwood MA, Ahmed M, Segler MH, et al. Artificial intelligence in drug discovery[J]. Future Med Chem, 2018, 10(17):2025-2028.
  [33] Walters WP, Murcko M. Assessing the impact of generative AI on medicinal chemistry[J]. Nat Biotechnol, 2020, 38(2):143-145.
  [34] 中国临床肿瘤学会指南工作委员会组织.中国临床肿瘤学会(CSCO)乳腺癌诊疗指南-2021[M].北京:人民卫生出版社, 2021.